• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Shareholders lawsuit against Unilife fizzles

January 23, 2014 By Brad Perriello

Shareholders lawsuit against Unilife fizzles

The plaintiff in a purported class action shareholders lawsuit against Unilife (NSDQ:UNIS) voluntarily withdrew the complaint after no other stockholders stepped up to join the suit.

Byron Brandt sued Unilife last November, a month after a pair of Forbes articles accusing Unilife of a raft of FDA and SEC violations pushed UNIS shares down 14% in a single day. The lawsuit accuses the drug delivery device maker and its senior managers of misleading investors about a key contract with pharma giant Sanofi (NYSE:SNY) and about the FDA status of 1 of its manufacturing plants.

Those accusations were spurred in part by another lawsuit filed by an ex-employee who made similar allegations. Unilife is contesting that lawsuit, saying it turned down a settlement offer and moved to dismiss 1 of the 3 claims made by Talbot "Todd" Smith, who was employed by Unilife as vice president, integrated supply chain from September 2011 to August 2012. Smith claims wrongful termination; Unilife claims he was slated to be let go anyway a part of a series of layoffs, according to court documents.

"As previously reported, the class action lawsuit was always considered to be frivolous and based mainly on the meritless allegations made by a former employee of the company," Unilife said today in a statement.

The Forbes articles last year prompted CEO Alan Shortall to go on the offensive, labeling the magazine’s pieces as "malicious" and "vindictive."

"I perceive both articles as a vindictive attack on me personally as well as the company and all of its followers and supporters," Shortall said at the time.

Since then Unilife has put up a string of wins, announcing supply deals with several pharmaceutical players, including an exclusive deal with Novartis (NYSE:NVS); a 15-year, $40 million supply deal with British drug maker Hikma Pharmaceuticals (LON:HIK); a similar pact with Medimmune, AstraZeneca’s (NYSE:AZN) biologics arm; a pact for its Ocu-ject eye drug delivery system with an unspecified company; and the long-term contract with Sanofi.

UNIS shares were trading at $4.77 apiece as of about 3:20 p.m. today, down 1.0%.

Filed Under: Drug-Device Combinations Tagged With: Unilife Corp.

IN CASE YOU MISSED IT

  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Embecta stock soars on first full-quarter results after BD spinoff
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Better Therapeutics Q2 beats Street as it prepares to submit diabetes therapy for FDA review
  • Study backs Fluidx embolic device for vessel filling

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS